Biotech: South Dakota revs up for the future in a young, growing industry

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding the state’s life science and biotechnology research industry.
Le Lézard

PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules

PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeotm MDMA ...

Strong Earnings and Biotech Resilience Define the Midweek Momentum

After decades of failed attempts by corporate giants and research consortia across the globe, Kraig Biocraft Laboratories (OTCQB: KBLB) appears poised to crack biotechnology's most persistent ...

Can Vir Biotechnology (NASDAQ:VIR) Afford To Invest In Growth?

So, the natural question for Vir Biotechnology (NASDAQ:VIR) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) ...

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine ...

The biotech industry is healthier than investors think. These are the stocks to watch.

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)

(GLOBE NEWSWIRE) -- (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that ...
PharmiWeb

What Is a Drug Launch? A Clear Guide to One of Biotech’s Most Critical Milestones

A drug launch is one of the most defining events in the pharma and biotech lifecycle. It marks the moment a therapy moves ...

MAIA Biotechnology Announces Open Market Purchases by CEO and Directors

Detailed price information for Maia Biotechnology Inc (MAIA-A) from The Globe and Mail including charting and trades.
sdnewswatch

Biotech: SD revs up for the future in a young, growing industry

SIOUX FALLS, S.D. — In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding the state's life science and biotechnology research ...

Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors

Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...
Le Lézard

Oncolytics Biotech® Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada

Oncolytics Biotech® Inc. ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced it has filed an amended registration statement on Form F-4 (the ...